Cytokinetics Inc

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing potential treatments for debilitating diseases in which muscle performance is compromised. As a leader in muscle biology and the mechanics of muscle performance, the company is developing small molecule drug candidates specifically engineered to impact muscle function and contractility for devastating cardiovascular and neuromuscular diseases, like heart failure, hypertrophic cardiomyopathy and amyotrophic lateral sclerosis. In 2023, Cytokinetics is celebrating its 25-year history of pioneering innovation in muscle biology and related pharmacology focused to diseases of muscle dysfunction and conditions of muscle weakness.